Evidence map›Paper›PMID 38610670›Full record

ArticleJournal of clinical medicine2024

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort.

Renaud Felten, Thibaut Fabacher, Nathanaël Sedmak, Jean Sibilia, Christelle Sordet, Emmanuel Chatelus, Francis Berenbaum, Bernard Combe, Adeline Ruyssen-Witrand, Olivier Vittecoq and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Renaud FeltenNational Reference Center for Rare Auto-Immune Diseasesest Sud-Ouest (RESO), Department of Rheumatology, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.ORCID 0000-0002-4951-4032
Thibaut FabacherDepartment of Public Health, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Nathanaël SedmakDepartment of Public Health, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Jean SibiliaNational Reference Center for Rare Auto-Immune Diseasesest Sud-Ouest (RESO), Department of Rheumatology, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Christelle SordetNational Reference Center for Rare Auto-Immune Diseasesest Sud-Ouest (RESO), Department of Rheumatology, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Emmanuel ChatelusNational Reference Center for Rare Auto-Immune Diseasesest Sud-Ouest (RESO), Department of Rheumatology, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Francis BerenbaumDepartment of Rheumatology, INSERM, AP-HP Saint-Antoine Hospital, Sorbonne University, 75005 Paris, France.ORCID 0000-0001-8252-7815
Bernard CombeFaculty of Medicine, Montpellier University, 34090 Montpellier, France.
Adeline Ruyssen-WitrandDepartment of Rheumatology, Toulouse University Toulouse III Paul Sabatier, 31400 Toulouse, France.
Olivier VittecoqDepartment of Rheumatology & CIC-CRB1404, Rouen University Hospital, Normandie University, UNIROUEN, 76000 Rouen, France.
Nicolas MeyerDepartment of Public Health, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.ORCID 0000-0001-6558-9731
Jacques-Eric GottenbergNational Reference Center for Rare Auto-Immune Diseasesest Sud-Ouest (RESO), Department of Rheumatology, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

comorbiditiesFIB-4prognostic factorrheumatoid arthritis

Identifiers

PMID38610670
PMCPMC11012698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.